Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Guidance On 'Significant Change' Meaning For Legacy Products Is Updated

Executive Summary

Now that the deadlines for legacy products under the EU’s Medical Device Regulation have been extended, the vital guidance on the meaning of “significant change” and conditions for ongoing sale of these products has also been updated.

You may also be interested in...



How Manufacturers Can Demonstrate Their 'Outdated' Legacy Certificates Remain Valid

It’s here! Notified bodies now have a means of showing which products are eligible to benefit from extended timelines as a result of the recent EU Medical Device Regulation amending regulation.

How And Where Tougher Clinical Evaluation Measures Under EU MDR Cause Challenges

A first of its kind study examines how large compared with medium companies are coping with the EU’s strict clinical evidence requirements. The results show how it is the more stringent demands for high-risk devices that are leading to device removals as well as market launch outside the EU.

Annex XVI Products Set To Have More Time To Comply With MDR

Devices without a clinical purpose that fall under the scope of the EU’s Medical Device Regulation need to be tightly regulated. Now it looks as though manufacturers will have more time to comply if they need it.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147918

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel